Cargando…
COVID-19 Vaccine Hesitancy Among Pregnant Women
Background COVID-19 has struck the world severely and caused much damage, losses, and a massive impact on different aspects of life. It is an airborne disease that spreads rapidly among populations and can cause severe illness or death. The rapid nature of its spread led to significant challenges to...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382906/ https://www.ncbi.nlm.nih.gov/pubmed/37519564 http://dx.doi.org/10.7759/cureus.41126 |
_version_ | 1785080779168022528 |
---|---|
author | Alkhalifah, Manal AlHusseini, Noara McGhee, John |
author_facet | Alkhalifah, Manal AlHusseini, Noara McGhee, John |
author_sort | Alkhalifah, Manal |
collection | PubMed |
description | Background COVID-19 has struck the world severely and caused much damage, losses, and a massive impact on different aspects of life. It is an airborne disease that spreads rapidly among populations and can cause severe illness or death. The rapid nature of its spread led to significant challenges to control it. With the introduction of vaccines, strategies need to be developed to prioritize high-risk populations to lower complication rates, hospitalization, and death. Pregnant women are considered a group of high-risk populations. Misinformation about the vaccination efficacy or side effects contributed to general hesitancy, especially among pregnant women. Purpose This study aims to describe the drivers of COVID-19 vaccine hesitancy among pregnant women in Saudi Arabia. Methodology This is a cross-sectional study among pregnant women in the OB/Gyn clinic in King Abdulaziz Medical City, Riyadh, Ministry of National Guard Health Affairs (MNG-HA), using an online survey. Descriptive statistics (univariate analysis) was used to examine the population characteristics. The Chi-square test was used for categorical variables, and t-test for continuous variables. Further, we used the logistics regression model (multivariate analysis), adjusted for potential confounders, to examine factors associated with women's hesitancy to take the COVID-19 vaccine. All statistical tests were two-sided, and findings were considered statistically significant at p < 0.05. All analyses were conducted using SAS statistical software version 9.4 (SAS Institute Inc., Cary, NC). Result The study included 303 pregnant women. Nearly half of the respondents had their vaccine during their pregnancy (42.24%), believing that the current vaccines' effectiveness for the coronavirus is good (41.25%). More than 73% of participants have received their COVID-19 vaccine before pregnancy. The mean hesitancy and anxiety score was 2 (agree), which concluded that the respondents were hesitant and anxious to receive the COVID-19 vaccine. Conclusion The study showed a significant correlation between pregnant women's worries and the intention to take the vaccine. The concerns were mainly about the impact of the vaccine on themselves, their babies, and the pregnancy. |
format | Online Article Text |
id | pubmed-10382906 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-103829062023-07-30 COVID-19 Vaccine Hesitancy Among Pregnant Women Alkhalifah, Manal AlHusseini, Noara McGhee, John Cureus Public Health Background COVID-19 has struck the world severely and caused much damage, losses, and a massive impact on different aspects of life. It is an airborne disease that spreads rapidly among populations and can cause severe illness or death. The rapid nature of its spread led to significant challenges to control it. With the introduction of vaccines, strategies need to be developed to prioritize high-risk populations to lower complication rates, hospitalization, and death. Pregnant women are considered a group of high-risk populations. Misinformation about the vaccination efficacy or side effects contributed to general hesitancy, especially among pregnant women. Purpose This study aims to describe the drivers of COVID-19 vaccine hesitancy among pregnant women in Saudi Arabia. Methodology This is a cross-sectional study among pregnant women in the OB/Gyn clinic in King Abdulaziz Medical City, Riyadh, Ministry of National Guard Health Affairs (MNG-HA), using an online survey. Descriptive statistics (univariate analysis) was used to examine the population characteristics. The Chi-square test was used for categorical variables, and t-test for continuous variables. Further, we used the logistics regression model (multivariate analysis), adjusted for potential confounders, to examine factors associated with women's hesitancy to take the COVID-19 vaccine. All statistical tests were two-sided, and findings were considered statistically significant at p < 0.05. All analyses were conducted using SAS statistical software version 9.4 (SAS Institute Inc., Cary, NC). Result The study included 303 pregnant women. Nearly half of the respondents had their vaccine during their pregnancy (42.24%), believing that the current vaccines' effectiveness for the coronavirus is good (41.25%). More than 73% of participants have received their COVID-19 vaccine before pregnancy. The mean hesitancy and anxiety score was 2 (agree), which concluded that the respondents were hesitant and anxious to receive the COVID-19 vaccine. Conclusion The study showed a significant correlation between pregnant women's worries and the intention to take the vaccine. The concerns were mainly about the impact of the vaccine on themselves, their babies, and the pregnancy. Cureus 2023-06-29 /pmc/articles/PMC10382906/ /pubmed/37519564 http://dx.doi.org/10.7759/cureus.41126 Text en Copyright © 2023, Alkhalifah et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Public Health Alkhalifah, Manal AlHusseini, Noara McGhee, John COVID-19 Vaccine Hesitancy Among Pregnant Women |
title | COVID-19 Vaccine Hesitancy Among Pregnant Women |
title_full | COVID-19 Vaccine Hesitancy Among Pregnant Women |
title_fullStr | COVID-19 Vaccine Hesitancy Among Pregnant Women |
title_full_unstemmed | COVID-19 Vaccine Hesitancy Among Pregnant Women |
title_short | COVID-19 Vaccine Hesitancy Among Pregnant Women |
title_sort | covid-19 vaccine hesitancy among pregnant women |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382906/ https://www.ncbi.nlm.nih.gov/pubmed/37519564 http://dx.doi.org/10.7759/cureus.41126 |
work_keys_str_mv | AT alkhalifahmanal covid19vaccinehesitancyamongpregnantwomen AT alhusseininoara covid19vaccinehesitancyamongpregnantwomen AT mcgheejohn covid19vaccinehesitancyamongpregnantwomen |